What is the current annual cash & cash equivalents of TMO?

As of today, TMO annual cash & cash equivalents is $10.11B

What is 1-year change in TMO annual cash & cash equivalents?

TMO annual cash & cash equivalents is up +81.18% year-over-year

What is 3-year change in TMO annual cash & cash equivalents?

TMO annual cash & cash equivalents is up +18.44% over the past 3 years

How far is TMO annual cash & cash equivalents from its all-time high?

TMO annual cash & cash equivalents is currently -2.18% below its historical high of $10.34B set on December 31, 2020

How does TMO annual cash & cash equivalents rank versus sector peers?

TMO annual cash & cash equivalents is higher than 99.12% of companies in Healthcare sector

When is TMO next annual earnings release?

The next annual earnings release for TMO is on January 28, 2027

What is the current quarterly cash & cash equivalents of TMO?

As of today, TMO quarterly cash & cash equivalents is $6.06B

What is TMO quarterly cash & cash equivalents most recent change?

TMO quarterly cash & cash equivalents was up +48.74% on September 26, 2026

What is 1-year change in TMO quarterly cash & cash equivalents?

TMO quarterly cash & cash equivalents is up +70.59% year-over-year

How far is TMO quarterly cash & cash equivalents from its all-time high?

TMO quarterly cash & cash equivalents is currently -49.69% below its historical high of $12.05B set on September 1, 2021

How does TMO quarterly cash & cash equivalents rank versus sector peers?

TMO quarterly cash & cash equivalents is higher than 98.19% of companies in Healthcare sector

When is TMO next earnings release?

The next earnings release for TMO is on January 28, 2027

TMO Cash & Equivalents History & Chart Since 1984

Annual Cash & Cash Equivalents

$10.11B$4.53B+81.18%

December 31, 2025

Summary

Current Value: As of today, TMO annual cash & cash equivalents is $10.11B, up +81.18% on December 31, 2025
Historical Performance: TMO annual cash & cash equivalents is up +18.44% over the past 3 years, down -2.18% over the past 5 years
All-Time High Comparison: TMO annual cash & cash equivalents is currently -2.18% below its historical high of $10.34B set on December 31, 2020
3-Year Low Comparison: TMO annual cash & cash equivalents is +81.18% above its 3-year low of $5.58B reached on December 31, 2024
Sector Comparison: TMO annual cash & cash equivalents is higher than 99.12% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

TMO Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$10.11B	+81.2%	+18.4%	-2.2%	+991.8%
Quarterly Cash & Cash Equivalents	Sep 26, 26	$6.06B	+70.6%	-1.6%	-49.7%	+574.7%
Price	Oct 29, 26	$706.66	+26.6%	+63.8%	+11.6%	+1274.8%
Annual Current Assets	Dec 31, 25	$28.71B	+29.7%	+13.8%	+30.7%	+594.2%
Annual Total Liabilities	Dec 31, 25	$56.81B	+19.2%	+7.2%	+64.5%	+848.6%
Annual Working Capital	Dec 31, 25	$13.52B	+53.5%	+64.5%	+16.0%	+457.4%
Annual Net Income	Dec 31, 25	$6.72B	+6.0%	-3.5%	+5.4%	+581.6%

Cash and Cash Equivalents Highs

TMO Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$10.11B	Dec 31, 25	at high
5Y	$10.34B	N/A	-2.2%
All	$10.34B	Dec 31, 20	-2.2%

Cash and Cash Equivalents Lows

TMO Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$5.58B	Dec 31, 24	+81.2%
5Y	$4.49B	Dec 31, 21	+125.2%
All	$11.40M	Dec 1, 84	>+9999.0%

Cash and Cash Equivalents History

Year	Value	Change
2025	$10.11B	+81.2%
2024	$5.58B	-31.0%
2023	$8.08B	-5.3%
2022	$8.54B	+90.1%
2021	$4.49B	-56.6%
2020	$10.34B	+327.1%
2019	$2.42B	+14.3%
2018	$2.12B	+54.7%
2017	$1.37B	+70.7%
2016	$802.00M	+72.2%
2015	$465.70M	-66.1%
2014	$1.37B	-76.7%
2013	$5.88B	+587.9%
2012	$855.30M	-16.2%
2011	$1.02B	+10.2%
2010	$926.00M	-41.1%
2009	$1.57B	+22.0%
2008	$1.29B	+101.5%
2007	$639.20M	-10.7%
2006	$715.60M	+142.6%

Year	Value	Change
2005	$294.99M	-42.4%
2004	$512.26M	+22.5%
2003	$418.24M	-52.2%
2002	$875.47M	-16.0%
2001	$1.04B	+1.5%
2000	$1.03B	+264.4%
1999	$281.76M	-81.8%
1998	$1.55B	+1.6%
1997	$1.52B	-17.5%
1996	$1.85B	+74.9%
1995	$1.06B	+5.8%
1994	$997.71M	+42.5%
1993	$700.19M	+89.9%
1992	$368.70M	-12.6%
1991	$421.77M	+209.2%
1988	$136.39M	+113.8%
1986	$63.80M	+112.6%
1985	$30.01M	+163.2%
1984	$11.40M	-

FAQ

What is the current annual cash & cash equivalents of TMO?: As of today, TMO annual cash & cash equivalents is $10.11B
What is 1-year change in TMO annual cash & cash equivalents?: TMO annual cash & cash equivalents is up +81.18% year-over-year
What is 3-year change in TMO annual cash & cash equivalents?: TMO annual cash & cash equivalents is up +18.44% over the past 3 years
How far is TMO annual cash & cash equivalents from its all-time high?: TMO annual cash & cash equivalents is currently -2.18% below its historical high of $10.34B set on December 31, 2020
How does TMO annual cash & cash equivalents rank versus sector peers?: TMO annual cash & cash equivalents is higher than 99.12% of companies in Healthcare sector
When is TMO next annual earnings release?: The next annual earnings release for TMO is on January 28, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$6.06B$1.99B+48.74%

September 26, 2026

Summary

Current Value: As of today, TMO quarterly cash & cash equivalents is $6.06B, up +48.74% on September 26, 2026
Historical Performance: TMO quarterly cash & cash equivalents is up +70.59% year-over-year, down -1.62% over the past 3 years
All-Time High Comparison: TMO quarterly cash & cash equivalents is currently -49.69% below its historical high of $12.05B set on September 1, 2021
3-Year Low Comparison: TMO quarterly cash & cash equivalents is +85.92% above its 3-year low of $3.26B reached on March 28, 2026
Sector Comparison: TMO quarterly cash & cash equivalents is higher than 98.19% of companies in Healthcare sector

Performance

TMO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 26, 26	$6.06B	+48.7%	+70.6%	-1.6%	-49.7%
Annual Cash & Cash Equivalents	Dec 31, 25	$10.11B	–	+81.2%	+18.4%	-2.2%
Price	Oct 29, 26	$706.66	+22.6%	+26.6%	+63.8%	+11.6%
Quarterly Current Assets	Sep 26, 26	$25.62B	+9.6%	+14.9%	+10.9%	+3.6%
Quarterly Total Liabilities	Sep 26, 26	$59.34B	-1.7%	+14.4%	+15.0%	+70.1%
Quarterly Working Capital	Sep 26, 26	$11.45B	+38.0%	+54.5%	+28.1%	-32.6%
Quarterly Net Income	Sep 26, 26	$1.74B	-0.2%	+7.3%	+2.6%	-8.6%

Quarterly Cash & Cash Equivalents Highs

TMO Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$10.11B	Dec 31, 25	-40.0%
3Y	$10.11B	Dec 31, 25	-40.0%
5Y	$12.05B	N/A	-49.7%
All	$12.05B	Sep 1, 21	-49.7%

Quarterly Cash & Cash Equivalents Lows

TMO Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$3.26B	Mar 28, 26	+85.9%
3Y	$3.26B	Mar 28, 26	+85.9%
5Y	$1.90B	Jun 1, 22	+218.3%
All	$11.40M	Dec 1, 84	>+9999.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$6.06B	+48.7%
Jun 2026	$4.08B	+25.0%
Mar 2026	$3.26B	-67.8%
Dec 2025	$10.11B	+184.5%
Sep 2025	$3.55B	-44.4%
Jun 2025	$6.39B	+7.2%
Mar 2025	$5.96B	+6.9%
Dec 2024	$5.58B	-16.2%
Sep 2024	$6.66B	-24.7%
Jun 2024	$8.83B	+21.7%
Mar 2024	$7.26B	-10.2%
Dec 2023	$8.08B	+31.2%
Sep 2023	$6.16B	+95.8%
Jun 2023	$3.15B	-9.9%
Mar 2023	$3.49B	-59.1%
Dec 2022	$8.54B	+191.0%
Sep 2022	$2.93B	+54.0%
Jun 2022	$1.90B	-31.5%
Mar 2022	$2.78B	-38.1%
Dec 2021	$4.49B	-62.7%
Sep 2021	$12.05B	+71.3%
Jun 2021	$7.03B	+25.6%
Mar 2021	$5.60B	-45.8%
Dec 2020	$10.34B	+36.5%
Sep 2020	$7.57B	+29.7%
Jun 2020	$5.84B	+94.0%
Mar 2020	$3.01B	+24.3%
Dec 2019	$2.42B	+85.6%
Sep 2019	$1.30B	-43.7%
Jun 2019	$2.32B	+104.0%
Mar 2019	$1.14B	-46.4%
Dec 2018	$2.12B	+88.6%
Sep 2018	$1.12B	+17.3%
Jun 2018	$957.00M	-2.3%
Mar 2018	$980.00M	-28.4%
Dec 2017	$1.37B	+81.2%
Sep 2017	$755.70M	+20.6%
Jun 2017	$626.80M	-14.5%
Mar 2017	$733.50M	-8.5%
Dec 2016	$802.00M	-59.3%
Sep 2016	$1.97B	+197.1%
Jun 2016	$663.10M	-19.8%
Mar 2016	$826.80M	+77.5%
Dec 2015	$465.70M	-7.5%
Sep 2015	$503.40M	-34.7%
Jun 2015	$770.40M	-11.8%
Mar 2015	$873.00M	-36.4%
Dec 2014	$1.37B	+152.4%
Sep 2014	$543.60M	-10.3%
Jun 2014	$605.90M	-60.2%
Mar 2014	$1.52B	-74.1%
Dec 2013	$5.88B	+205.0%
Sep 2013	$1.93B	+36.5%
Jun 2013	$1.41B	+40.1%
Mar 2013	$1.01B	+17.9%
Dec 2012	$855.30M	+2.2%
Sep 2012	$836.50M	+13.6%
Jun 2012	$736.60M	-7.1%
Mar 2012	$792.60M	-22.3%
Dec 2011	$1.02B	+13.6%
Sep 2011	$898.30M	-34.1%
Jun 2011	$1.36B	-51.2%
Mar 2011	$2.79B	+201.7%
Dec 2010	$926.00M	-1.4%
Sep 2010	$939.30M	-34.8%
Mar 2010	$1.44B	-8.3%
Dec 2009	$1.57B	-10.5%
Sep 2009	$1.76B	+23.1%
Jun 2009	$1.43B	-9.1%

Month	Value	Change
Mar 2009	$1.57B	+21.9%
Dec 2008	$1.29B	+3.1%
Sep 2008	$1.25B	+22.5%
Jun 2008	$1.02B	+36.4%
Mar 2008	$748.10M	+17.0%
Dec 2007	$639.20M	-24.5%
Sep 2007	$846.20M	-13.1%
Jun 2007	$973.90M	+40.9%
Mar 2007	$691.40M	-3.4%
Dec 2006	$715.60M	+314.5%
Sep 2006	$172.64M	-12.8%
Jun 2006	$197.98M	-36.2%
Mar 2006	$310.55M	+5.3%
Dec 2005	$294.99M	+45.9%
Sep 2005	$202.15M	+18.4%
Jun 2005	$170.81M	-67.7%
Mar 2005	$528.60M	+42.2%
Jun 2004	$371.79M	-57.5%
Dec 2002	$875.47M	+2.2%
Sep 2002	$856.26M	-16.6%
Dec 2000	$1.03B	+22.6%
Dec 1999	$837.26M	-26.2%
Sep 1999	$1.13B	+6.2%
Jun 1999	$1.07B	-7.8%
Mar 1999	$1.16B	-25.2%
Dec 1998	$1.55B	+271.8%
Sep 1998	$416.10M	-31.9%
Jun 1998	$611.00M	+2.6%
Mar 1998	$595.70M	+0.4%
Dec 1997	$593.60M	+20.3%
Sep 1997	$493.30M	+70.9%
Jun 1997	$288.70M	-15.5%
Mar 1997	$341.80M	-17.5%
Dec 1996	$414.40M	-18.2%
Sep 1996	$506.50M	-6.4%
Jun 1996	$541.20M	-30.1%
Mar 1996	$774.70M	+67.7%
Dec 1995	$462.00M	+4.6%
Sep 1995	$441.60M	-16.5%
Jun 1995	$528.90M	+30.2%
Mar 1995	$406.30M	+6.1%
Dec 1994	$382.80M	+24.6%
Sep 1994	$307.20M	+6.0%
Jun 1994	$289.70M	+12.5%
Mar 1994	$257.60M	-20.9%
Dec 1993	$325.70M	-5.8%
Sep 1993	$345.60M	+325.1%
Jun 1993	$81.30M	-24.3%
Mar 1993	$107.40M	-43.7%
Dec 1992	$190.60M	+14.7%
Sep 1992	$166.20M	+22.7%
Jun 1992	$135.50M	-7.5%
Mar 1992	$146.50M	+11.8%
Dec 1991	$131.00M	+18.1%
Sep 1991	$110.90M	+1.2%
Jun 1991	$109.60M	-19.0%
Mar 1991	$135.30M	+14.8%
Dec 1990	$117.90M	+40.0%
Sep 1990	$84.20M	+68.7%
Jun 1990	$49.90M	-27.9%
Mar 1990	$69.20M	-26.3%
Dec 1989	$93.90M	+45.4%
Sep 1989	$64.60M	-52.6%
Dec 1988	$136.40M	-5.3%
Dec 1987	$144.10M	+125.9%
Dec 1986	$63.80M	+112.7%
Dec 1985	$30.00M	+163.2%
Dec 1984	$11.40M	-

FAQ

What is the current quarterly cash & cash equivalents of TMO?: As of today, TMO quarterly cash & cash equivalents is $6.06B
What is TMO quarterly cash & cash equivalents most recent change?: TMO quarterly cash & cash equivalents was up +48.74% on September 26, 2026
What is 1-year change in TMO quarterly cash & cash equivalents?: TMO quarterly cash & cash equivalents is up +70.59% year-over-year
How far is TMO quarterly cash & cash equivalents from its all-time high?: TMO quarterly cash & cash equivalents is currently -49.69% below its historical high of $12.05B set on September 1, 2021
How does TMO quarterly cash & cash equivalents rank versus sector peers?: TMO quarterly cash & cash equivalents is higher than 98.19% of companies in Healthcare sector
When is TMO next earnings release?: The next earnings release for TMO is on January 28, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

TMO Official Website www.thermofisher.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo